SABRA HEALTH CARE REIT, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $774.6M | $703.2M | $647.5M | $624.8M | $569.5M | $598.6M | $661.7M | $623.4M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $53.7M | $50.1M | $47.5M | $39.6M | $34.7M | $32.8M | $30.9M | $37.1M |
| Operating Income | $265.9M | $243.4M | $131.6M | $127.1M | $179.3M | $256.2M | $205.8M | $434.7M |
| Operating Margin | 34.3% | 34.6% | 20.3% | 20.3% | 31.5% | 42.8% | 31.1% | 69.7% |
| Interest Expense | $112.5M | $115.3M | $113.0M | $105.5M | $98.6M | $100.4M | $126.6M | $147.1M |
| Pretax Income | $153.4M | $128.1M | $18.7M | $21.7M | $80.7M | $155.7M | $79.2M | $287.6M |
| Income Tax Expense | $1.8M | $1.0M | $2.0M | $1.2M | $1.8M | $710.0K | $3.4M | $3.0M |
| Net Income | $155.6M | $126.7M | $13.8M | $-77.6M | $-113.3M | $138.4M | $69.0M | $279.1M |
| Net Margin | 20.1% | 18.0% | 2.1% | -12.4% | -19.9% | 23.1% | 10.4% | 44.8% |
| EPS (Basic) | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 | $0.37 | $1.51 |
| EPS (Diluted) | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 | $0.37 | $1.51 |
| Shares Outstanding (Basic) | 241.3M | 233.5M | 231.2M | 230.9M | 219.1M | 206.2M | 187.2M | 178.3M |
| Shares Outstanding (Diluted) | 244.5M | 236.0M | 232.8M | 230.9M | 219.1M | 207.3M | 188.1M | 178.7M |
| Dividends Per Share | $1.20 | $1.20 | $1.20 | $1.20 | $1.20 | $1.35 | $1.80 | $1.80 |